- Pre-seed stage companies
- Seed stage companies
- Series A companies
- Diverse and women first-time founders
- Academic/corporate spin-offs
- Non-U.S. clusters seeking pre-commercial foothold in CA
FAST California provides founders of disruptive innovative life science technology companies with a customized advisory program to perfect their business models, assess strategic focus, maximize IP and help develop a milestone and scale-up plan to exit. A group of curated advisors, each with deep domain expertise, will work with them over twelve weeks to build a compelling commercialization strategy and prepare them for an Innovation Showcase to a curated audience of potential investors and collaboration partners.
First-time founders learn what it takes to close the deal on a Seed or Series A round with venture capital funds and/or angel investors. Case study discussions and other practical tips to set up a successful funding round and strategy, including negotiation tips with lead investors and other insights in a series of five recorded workshops.
Watch On Demand
Through our Innovation Showcases and exclusive opportunities for our members at industry leading partnering and investor conferences, CLS connects early-stage innovators with funding sources, mentorship, and opportunities to present to the industry.
CLS’s Innovation Showcase (held twice a year at the conclusion of the FAST spring and fall program), creates a unique experience for the start-up community to spotlight FAST graduates and California’s entrepreneurship. Audience attendance of approximately 300+ life science stakeholders including biopharma representatives, investors, key advisors, expert service providers. Join us Dec. 12, 2023.
CLS provides non-U.S.-based clusters seeking to grow their regional economies with the resources and counsel to establish a commercial foothold in U.S. markets and connects them to the resources required to develop subsidiaries or commercial spin-offs in the United States.